Explore whether patients actually choose authorized generics over traditional ones. We analyze switchback rates, pricing dynamics, and the hidden role of insurance in your medication choices.
VIEW MOREGeneric medications save billions but fail if patients don’t trust them. Pharmacists must explain bioequivalence, appearance changes, and safety to prevent non-adherence. Here’s what to say-and why it matters.
VIEW MORENTI drugs like levothyroxine and tacrolimus have a narrow safety margin. Switching between generic manufacturers can affect blood levels and cause serious side effects - even when generics pass FDA tests. Here’s what you need to know.
VIEW MOREBig pharma companies are using legal loopholes to block generic drugs from replacing brand-name medicines, costing patients billions. Learn how product hopping, REMS abuse, and withdrawal tactics undermine pharmacy substitution laws - and who’s fighting back.
VIEW MORE